Abstract
Greater availability of therapeutic radioisotopes is required to meet the demands for increasing clinical applications in nuclear medicine, oncology and interventional cardiology. Because of the need for very high specific activity products, methods other than direct neutron capture reactions (n,γ-elastic and n,n’-inelastic routes) are required to insure that the highest specific activity - and hopefully no carrier added (nca) - radioisotopes are available. Two major methods to obtain nca radioisotopes from reactors are through the use of radionuclide generator systems using reactor-produced parents and the formation of desired radioisotopes through beta-decay of reactor-produced species. In this paper we describe our recent development of new approaches to obtain nca 177Lu from the decay of reactor-produced 177Yb and free of the long-lived 177mLu (T1/2 = 160 d) radiocontaminant. We also describe preliminary results of our new “indirect” method for the production of 195mPt via decay of 195mIr, reactor-produced by neutron irradiation of highly enriched 193Ir.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
